Howard Schwartz

3.7k total citations
27 papers, 1.3k citations indexed

About

Howard Schwartz is a scholar working on Epidemiology, Surgery and Gastroenterology. According to data from OpenAlex, Howard Schwartz has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Surgery and 5 papers in Gastroenterology. Recurrent topics in Howard Schwartz's work include Helicobacter pylori-related gastroenterology studies (6 papers), Gastroesophageal reflux and treatments (5 papers) and Influenza Virus Research Studies (4 papers). Howard Schwartz is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (6 papers), Gastroesophageal reflux and treatments (5 papers) and Influenza Virus Research Studies (4 papers). Howard Schwartz collaborates with scholars based in United States, Japan and Australia. Howard Schwartz's co-authors include Loren Laine, Thomas Simon, Steven H. Stern, S. E. Harper, R. N. Bath, James A. Bolognese, Hui Quan, John F. Johanson, Nimish Vakil and Jay Barth and has published in prestigious journals such as Nature Communications, Gastroenterology and Neurology.

In The Last Decade

Howard Schwartz

27 papers receiving 1.2k citations

Peers

Howard Schwartz

SURGE

PHARM

GASTR

EPIDE

PRM

Mark Feeney United Kingdom

Lyndon E. Mansfield United States

F. Y. Chang Taiwan

Peter Christopher Konturek Germany

Filippo Bernardi Italy

Cheryl A. Black United States

Pavel Krugliak Israel

Pontus Karling Sweden

D G Maxton United Kingdom

Kelly C. Cushing United States

Mark Feeney United Kingdom

Howard Schwartz

360 ×0.7

SURGE

413 ×1.2

PHARM

97 ×0.3

GASTR

127 ×0.5

EPIDE

235 ×1.6

PRM

Citations per year, relative to Howard Schwartz Howard Schwartz (= 1×) peers Mark Feeney

Countries citing papers authored by Howard Schwartz

Since Specialization

Citations

This map shows the geographic impact of Howard Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Schwartz more than expected).

Fields of papers citing papers by Howard Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Schwartz. The network helps show where Howard Schwartz may publish in the future.

Co-authorship network of co-authors of Howard Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Schwartz. A scholar is included among the top collaborators of Howard Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Schwartz. Howard Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robbins, Jonathan A., Scott A. Sands, Tami Crumley, et al.. (2024). Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial. Journal of Clinical Sleep Medicine. 20(12). 1905–1913. 4 indexed citations

Fierro, Carlos, Daniel C. Brune, Howard Schwartz, et al.. (2024). Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial. The Journal of Infectious Diseases. 230(3). e668–e678. 28 indexed citations

Severance, Randall, Howard Schwartz, Ron Dagan, et al.. (2021). Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU). Human Vaccines & Immunotherapeutics. 18(1). 1–14. 16 indexed citations

Eiden, Joseph E., Ruth D. Ellis, Carlos Fierro, et al.. (2020). 33. Intranasal M2SR (M2-deficient Single Replication) Live H3N2 Influenza Investigational Vaccine Induces Serum HAI & Broad Immune Responses in High Proportion of Adults. Open Forum Infectious Diseases. 7(Supplement_1). S40–S41. 2 indexed citations

Everson, Gregory T., Karen Sims, Paul J. Thuluvath, et al.. (2015). Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1‐infected treatment‐naive patients. Liver International. 36(2). 189–197. 21 indexed citations

Hassanein, Tarek, Karen Sims, Melanie E. Bennett, et al.. (2014). P1163 ALL-ORAL THERAPY WITH DACLATASVIR IN COMBINATION WITH ASUNAPREVIR AND BMS-791325 FOR TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE 4 INFECTION. Journal of Hepatology. 60(1). S472–S472. 9 indexed citations

Sulkowski, Mark, David Gardiner, E. Läwitz, et al.. (2012). 1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3. Journal of Hepatology. 56. S560–S560. 70 indexed citations

Rosenberg, Russell, David Seiden, Steven Hull, et al.. (2008). APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia. SLEEP. 31(12). 1663–1671. 33 indexed citations

Kalman, Douglas, et al.. (2008). Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint®) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial. Nutrition Journal. 7(1). 3–3. 49 indexed citations

10.

Zammit, Gary, et al.. (2008). The effects of ramelteon in a first-night model of transient insomnia. Sleep Medicine. 10(1). 55–59. 35 indexed citations

11.

Röth, Thomas, Steven Hull, Howard Schwartz, et al.. (2007). Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia. SLEEP. 30(11). 1555–1561. 111 indexed citations

12.

Goldstein, Jay L., James Aisenberg, Frank L. Lanza, et al.. (2006). A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Clinical Therapeutics. 28(3). 340–351. 18 indexed citations

13.

Vakil, Nimish, François Lanza, Howard Schwartz, & Jay Barth. (2004). Seven‐day therapy for Helicobacter pylori in the United States. Alimentary Pharmacology & Therapeutics. 20(1). 99–107. 140 indexed citations

14.

Schwartz, Howard. (2002). Helicobacter pylori eradication with rabeprazole-based triple therapy: findings in 803 patients with antibiotic-sensitive and -resistant strains. The American Journal of Gastroenterology. 97(9). S21–S21. 1 indexed citations

15.

Talley, Nicholas J., Dennis Riff, Howard Schwartz, & Stefan P. Marcuard. (2001). Double‐blind placebo‐controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 15(10). 1603–1611. 27 indexed citations

16.

Laine, Loren, S. E. Harper, Thomas Simon, et al.. (1999). A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology. 117(4). 776–783. 357 indexed citations

17.

Creticos, Peter S., Philip Fireman, Guy A. Settipane, et al.. (1998). Intranasal Budesonide Aqueous Pump Spray (Rhinocort^® Aqua) for the Treatment of Seasonal Allergic Rhinitis. Allergy and Asthma Proceedings. 19(5). 285–294. 28 indexed citations

18.

Schwartz, Howard, Richard A. Krause, Mateusz Haber, et al.. (1998). Triple Versus Dual Therapy for Eradicating Helicobacter pylori and Preventing Ulcer Recurrence: A Randomized, Double-Blind, Multicenter Study of Lansoprazole, Clarithromycin, and/or Amoxicillin in Different Dosing Regimens. The American Journal of Gastroenterology. 93(4). 584–590. 75 indexed citations

19.

Schwartz, Howard, et al.. (1996). Seven‐Day Triple Therapy with Lansoprazole, Clarithromycin, and Metronidazole for the Cure of Helicobacter pylori Infection: A Short Report. Helicobacter. 1(4). 251–255. 27 indexed citations

20.

Schwartz, Howard, et al.. (1969). Communication and non‐western cultures: Parameters for study. Today s Speech. 17(1). 39–42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact